CVS Health Corp.’s drug benefits unit is trying to entice health insurance plans to cover Wegovy, Novo Nordisk A/S’s pricey ...

CVS Health Corp.’s drug benefits unit is trying to entice health insurance plans to cover Wegovy, Novo Nordisk A/S’s pricey weight-loss shot, for more patients by allowing them to charge copays as ...

It only arrived in the UK a little over 20 months ago, but since its release, Mounjaro has transformed the market for GLP-1 medicines, with more than half of the 1.5 million people taking weight-loss ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide ...